|Bid||37.71 x 2300|
|Ask||37.73 x 4100|
|Day's Range||37.71 - 37.72|
|52 Week Range||30.71 - 38.06|
|PE Ratio (TTM)||N/A|
|Expense Ratio (net)||0.30%|
The correlation between US and international markets varies depending on market cycles.
The acquisition of Allergan’s (AGN) generic business has helped Teva's R&D pipeline become the strongest generic drug pipeline in the world.
Teva is in the first three positions in 26 countries in the European Union. The Teva–Allergan Generics deal helped Teva expand.